{"@id":"https://bioecon.ru/technology/amyloid-pore-inhibitors/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/amyloid-pore-inhibitors/","json":"https://en.bioecon.ru/api/v1/technology/amyloid-pore-inhibitors/index.json"},"id":"amyloid-pore-inhibitors","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/genscript-probio-genscript/","https://bioecon.ru/companies/vci-technology-sdn-bhd/","https://bioecon.ru/companies/astrazeneca/","https://bioecon.ru/companies/atomwise/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/21st-bio/","https://bioecon.ru/companies/newlimit/","https://bioecon.ru/companies/evogene/","https://bioecon.ru/companies/a-costantino-c-spa/"]},"maturity":7,"name":"Amyloid Pore Inhibitors","regions":["ch","eu","us","cn"],"risk":"medium","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Annular pore structure modeling"},{"n":2,"title":"Electrophysiological channel plugging"},{"n":3,"title":"Neuronal calcium preservation"},{"n":4,"title":"Cognitive benefit in vivo"}],"summary":"Structure-designed small molecules and cyclic peptides that physically bind and plug toxic annular amyloid oligomer pores in neuronal cell membranes, neutralizing catastrophic calcium dysregulation in Alzheimer's and Parkinson's diseases.","url":"/technology/amyloid-pore-inhibitors/","verified":"2026-11-22"}